Cerulean

edit

Cerulean Pharma Inc. is a privately-held biopharmaceutical company focused on the development of novel nanotechnology-based therapeutics in the areas of oncology, cardiovascular, autoimmune and inflammatory diseases.

The Company has assembled a world-class management team, board of directors and scientific advisory board that collectively have a significant track record of business building, product development and scientific breakthroughs from companies and institutions such as Cubist, GlaxoSmithKline, Merck, Millennium Pharmaceuticals, Inc., Pfizer, Wyeth, the Massachusetts Institute of Technology, Harvard Medical School, MD Anderson, Fox Chase Cancer Center and the Arizona Health Center.

Milestones

edit

• 
  Cerulean received $10M in Series B funding. (7/28/09)
  Posted 7/28/09 at 2:28pm

Videos

Screenshots

edit

Sources

1. Cerulean pockets $10M as it catapults into the clinic (fiercebiotech.com) [edit]